1. Sharir T, Slomka PJ, Berman DS: Solid state SPECT technology: fast and furious. J Nucl Cardiol 2010, 17:890–896.
2. Feng B, Pretorius PH, Farncombe TH, Dahlberg ST, Narayanan MV, Wernick MN, Celler AM, Leppo JA, King MA: Simultaneous assessment of cardiac perfusion and function using 5-dimensional imaging with Tc-99m teboroxime. J Nucl Cardiol 2006, 13:354–361.
3. Stewart RE, Schwaiger M, Hutchins GD, Chiao PC, Gallagher KP, Nguyen N, Petry NA, Rogers WL: Myocardial clearance kinetics of technetium-99m-SQ30217: a marker of regional myocardial blood flow. J Nucl Med 1990, 31:1183–1190.
4. Stewart RE, Heyl B, O'Rourke RA, Blumhardt R, Miller DD: Demonstration of differential post-stenotic myocardial technetium-99m-teboroxime clearance kinetics after experimental ischemia and hyperemic stress. J Nucl Med 1991, 32:2000–2008.
5. Johnson G 3rd, Glover DK, Hebert CB, Okada RD: Myocardial technetium 99m-labeled teboroxime clearance derived from canine scans differentiates severity of stenosis after dipyridamole. J Nucl Cardiol 1994, 1:338–350.